,
Peters, Tanja
Soanes, Nigel
Abbas, Maya
Ahmad, Jabeen
Delumeau, Jean-Christophe https://orcid.org/0000-0002-1116-8234
Herrero-Martinez, Esteban
Paramananda, Mélanie
Piper, Johanna
Smail-Aoudia, Fairouz
van der Spuij, Willemijn
Veizovic, Tina
Winstanley, Gillian
Article History
Accepted: 27 September 2020
First Online: 8 December 2020
Declarations
:
: Tanja Peters: funding for this research included working hours dedicated to this research remunerated by Boehringer Ingelheim as part of salary. No additional sources of funding were stated by the authors as being used to assist in the preparation of this study.
: Tanja Peters was employed at Boehringer Ingelheim at the time this research was completed. As of April 1, 2020, Tanja Peters is an employee of Merck Healthcare KGaA and owns stocks of Merck KGaA. Tanja Peters also conducts ancillary work with the Forum Institute for Professional Training in Heidelberg, Germany. Nigel Soanes is employed by AstraZeneca and has reported no additional conflicts of interest. Maya Abbas is employed by Johnson & Johnson Middle East and declares that she has no conflict of interest. Jabeen Ahmad was previously employed by AbbVie and Innovate PV during the writing of the manuscript. Jabeen is now employed by Roche and has reported no conflicts of interest. Jean-Christophe Delumeau is employed by Bayer, serving <i>pro bono</i> the International Society of Pharmacovigilance as a board and executive committee member. He has not reported additional conflicts of interest. Esteban Herrero-Martinez is employed by AbbVie and has reported no additional conflicts of interest. Mélanie Paramananda is employed by Pierre Fabre and has reported no additional conflicts of interest. Johanna Piper is employed by Roche Products Ltd and has reported no additional conflicts of interest. Fairouz Smail-Aoudia is employed by Pierre Fabre and has reported no additional conflicts of interest. Willemijn van der Spuij is employed by Bristol Myers Squibb and has reported no additional conflicts of interest. Tina Veizovic is employed by Takeda and has reported no additional conflicts of interest. Gillian Winstanley is employed by Amgen Canada Inc. and has reported no additional conflicts of interest.
: Not applicable, as this article does not refer to data relative to individuals.
: Not applicable, as this article does not refer to data relative to individuals.
: Not applicable, as this article does not refer to data relative to individuals.
: Data sharing is not applicable to this article as no datasets were generated or analysed during the current study. The materials referred to in this article consist of guidelines and legislation publicly available on the websites of the respective institutions.
: Not applicable, as no computer system was used for data compilation or analysis.
: All authors contributed to the conception and writing of the review. All Authors read and approved the manuscript.